Rafeul Alam
Concepts (443)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Asthma | 39 | 2023 | 2042 | 6.010 |
Why?
| Th2 Cells | 12 | 2022 | 154 | 3.490 |
Why?
| Lymphocytes | 9 | 2023 | 333 | 3.110 |
Why?
| Immunity, Innate | 9 | 2023 | 725 | 2.850 |
Why?
| Adaptor Proteins, Signal Transducing | 9 | 2012 | 369 | 1.880 |
Why?
| Hypersensitivity | 9 | 2017 | 256 | 1.800 |
Why?
| Intracellular Signaling Peptides and Proteins | 7 | 2021 | 386 | 1.650 |
Why?
| Cytokines | 16 | 2023 | 1843 | 1.630 |
Why?
| Drug Hypersensitivity | 4 | 2016 | 85 | 1.600 |
Why?
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 4 | 2021 | 21 | 1.590 |
Why?
| Eosinophils | 8 | 2014 | 280 | 1.580 |
Why?
| Th17 Cells | 4 | 2016 | 59 | 1.490 |
Why?
| Allergens | 9 | 2023 | 417 | 1.190 |
Why?
| Desensitization, Immunologic | 5 | 2014 | 117 | 1.170 |
Why?
| Signal Transduction | 15 | 2021 | 4525 | 1.090 |
Why?
| Aspirin | 3 | 2016 | 324 | 1.090 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2016 | 299 | 1.080 |
Why?
| Mitogen-Activated Protein Kinase 3 | 6 | 2021 | 146 | 1.070 |
Why?
| CD4-Positive T-Lymphocytes | 7 | 2021 | 966 | 1.070 |
Why?
| Respiratory Tract Diseases | 3 | 2016 | 140 | 1.050 |
Why?
| Drug Resistance | 2 | 2017 | 158 | 1.010 |
Why?
| Interleukin-33 | 6 | 2020 | 38 | 0.990 |
Why?
| Bronchoalveolar Lavage | 2 | 2014 | 84 | 0.940 |
Why?
| Immunologic Deficiency Syndromes | 3 | 2010 | 66 | 0.940 |
Why?
| Interleukin-1 Receptor-Like 1 Protein | 3 | 2020 | 22 | 0.930 |
Why?
| Immunologic Memory | 4 | 2021 | 313 | 0.900 |
Why?
| Interleukin-13 | 5 | 2020 | 122 | 0.880 |
Why?
| Lymphocyte Subsets | 2 | 2017 | 79 | 0.850 |
Why?
| Neutrophils | 5 | 2020 | 1164 | 0.830 |
Why?
| Biomarkers | 8 | 2022 | 3418 | 0.820 |
Why?
| Humans | 83 | 2022 | 114937 | 0.800 |
Why?
| Respiration | 2 | 2013 | 180 | 0.790 |
Why?
| MAP Kinase Signaling System | 4 | 2021 | 276 | 0.780 |
Why?
| Membrane Proteins | 3 | 2021 | 1022 | 0.770 |
Why?
| MAP Kinase Kinase 1 | 2 | 2012 | 66 | 0.770 |
Why?
| Animals | 41 | 2023 | 31839 | 0.750 |
Why?
| Mice | 30 | 2023 | 14936 | 0.750 |
Why?
| src-Family Kinases | 4 | 2012 | 88 | 0.740 |
Why?
| Cell Differentiation | 4 | 2020 | 1699 | 0.730 |
Why?
| Mutation, Missense | 2 | 2012 | 295 | 0.700 |
Why?
| Interleukin-7 Receptor alpha Subunit | 1 | 2020 | 11 | 0.700 |
Why?
| Receptors, Prostaglandin | 1 | 2020 | 22 | 0.700 |
Why?
| Lymphocyte Activation | 7 | 2021 | 1045 | 0.680 |
Why?
| Interleukin-4 | 6 | 2014 | 208 | 0.680 |
Why?
| Microtubule Proteins | 3 | 2009 | 15 | 0.680 |
Why?
| T-Lymphocytes | 9 | 2016 | 1749 | 0.660 |
Why?
| Interleukin-17 | 7 | 2020 | 104 | 0.660 |
Why?
| Respiratory System | 3 | 2019 | 138 | 0.640 |
Why?
| Receptors, Immunologic | 1 | 2020 | 201 | 0.630 |
Why?
| Mast Cells | 3 | 2014 | 117 | 0.630 |
Why?
| Sinusitis | 4 | 2020 | 175 | 0.620 |
Why?
| Transforming Growth Factor beta | 3 | 2010 | 449 | 0.610 |
Why?
| Interleukins | 3 | 2015 | 236 | 0.600 |
Why?
| Interleukin-9 | 1 | 2017 | 10 | 0.600 |
Why?
| STAT6 Transcription Factor | 2 | 2018 | 22 | 0.570 |
Why?
| Epigenesis, Genetic | 1 | 2021 | 523 | 0.560 |
Why?
| Skin | 2 | 2012 | 659 | 0.560 |
Why?
| Food Hypersensitivity | 2 | 2011 | 254 | 0.530 |
Why?
| Mice, Knockout | 8 | 2021 | 2587 | 0.520 |
Why?
| Cells, Cultured | 10 | 2020 | 3897 | 0.520 |
Why?
| Anti-Asthmatic Agents | 2 | 2021 | 350 | 0.520 |
Why?
| p38 Mitogen-Activated Protein Kinases | 4 | 2016 | 262 | 0.510 |
Why?
| Inflammation Mediators | 3 | 2017 | 476 | 0.510 |
Why?
| B-Cell Activation Factor Receptor | 1 | 2015 | 13 | 0.500 |
Why?
| Immunoglobulins, Intravenous | 3 | 2015 | 122 | 0.500 |
Why?
| Active Transport, Cell Nucleus | 2 | 2012 | 110 | 0.490 |
Why?
| Urticaria | 2 | 2013 | 50 | 0.490 |
Why?
| Common Variable Immunodeficiency | 1 | 2015 | 27 | 0.490 |
Why?
| Antibodies, Blocking | 1 | 2015 | 32 | 0.490 |
Why?
| Epithelial Cells | 5 | 2019 | 958 | 0.490 |
Why?
| Hematopoietic Stem Cell Transplantation | 2 | 2010 | 525 | 0.480 |
Why?
| Enzyme Activation | 7 | 2012 | 790 | 0.480 |
Why?
| Receptors, Antigen, T-Cell | 2 | 2011 | 620 | 0.470 |
Why?
| Inflammation | 10 | 2022 | 2485 | 0.470 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2008 | 278 | 0.460 |
Why?
| Mitogen-Activated Protein Kinase 1 | 3 | 2010 | 164 | 0.460 |
Why?
| Mice, Inbred BALB C | 8 | 2019 | 1153 | 0.460 |
Why?
| Mastocytosis | 1 | 2014 | 12 | 0.460 |
Why?
| Severe Combined Immunodeficiency | 2 | 2012 | 19 | 0.450 |
Why?
| Angioedema | 1 | 2013 | 16 | 0.440 |
Why?
| Cell Proliferation | 7 | 2021 | 2199 | 0.430 |
Why?
| Vehicle Emissions | 3 | 2020 | 48 | 0.430 |
Why?
| Nuclear Receptor Co-Repressor 2 | 1 | 2012 | 14 | 0.430 |
Why?
| Nuclear Receptor Co-Repressor 1 | 1 | 2012 | 16 | 0.420 |
Why?
| Health | 1 | 2013 | 74 | 0.420 |
Why?
| Interleukin-5 | 4 | 2010 | 30 | 0.420 |
Why?
| T-Lymphocytes, Helper-Inducer | 2 | 2017 | 128 | 0.420 |
Why?
| Pyrrolidinones | 1 | 2012 | 25 | 0.410 |
Why?
| Plethysmography, Impedance | 1 | 2012 | 5 | 0.410 |
Why?
| Immune Tolerance | 3 | 2012 | 328 | 0.410 |
Why?
| Lymphopenia | 1 | 2012 | 50 | 0.410 |
Why?
| Phenotype | 4 | 2017 | 2817 | 0.410 |
Why?
| Janus Kinases | 1 | 2012 | 12 | 0.410 |
Why?
| Skin Diseases, Vesiculobullous | 1 | 2012 | 17 | 0.400 |
Why?
| rab GTP-Binding Proteins | 2 | 2010 | 63 | 0.400 |
Why?
| T-Lymphocytopenia, Idiopathic CD4-Positive | 1 | 2011 | 7 | 0.400 |
Why?
| Chemical Industry | 1 | 2011 | 9 | 0.400 |
Why?
| Asthma, Occupational | 1 | 2011 | 4 | 0.390 |
Why?
| Bronchial Hyperreactivity | 4 | 2015 | 95 | 0.390 |
Why?
| Adrenal Cortex Hormones | 1 | 2015 | 499 | 0.380 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2017 | 1893 | 0.380 |
Why?
| Mice, Inbred C57BL | 9 | 2021 | 4719 | 0.380 |
Why?
| Rhinitis, Allergic, Perennial | 1 | 2011 | 23 | 0.380 |
Why?
| Phleum | 4 | 2017 | 4 | 0.380 |
Why?
| Rhinitis, Allergic, Seasonal | 1 | 2011 | 32 | 0.380 |
Why?
| Endocytosis | 2 | 2009 | 151 | 0.380 |
Why?
| Adoptive Transfer | 3 | 2021 | 198 | 0.370 |
Why?
| Phosphorylation | 5 | 2021 | 1572 | 0.370 |
Why?
| Capillary Permeability | 2 | 2010 | 135 | 0.360 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 3 | 2021 | 157 | 0.350 |
Why?
| Lactic Acid | 1 | 2011 | 275 | 0.350 |
Why?
| Sputum | 2 | 2017 | 285 | 0.340 |
Why?
| Enzyme Stability | 1 | 2010 | 62 | 0.340 |
Why?
| Disease Models, Animal | 7 | 2021 | 3549 | 0.340 |
Why?
| Dynamins | 1 | 2009 | 29 | 0.340 |
Why?
| Respiratory Function Tests | 3 | 2017 | 524 | 0.340 |
Why?
| Interleukin-10 | 2 | 2010 | 296 | 0.330 |
Why?
| Immunological Synapses | 1 | 2009 | 18 | 0.330 |
Why?
| Psychoneuroimmunology | 1 | 2009 | 11 | 0.330 |
Why?
| Ambrosia | 1 | 2009 | 7 | 0.330 |
Why?
| Aspergillus | 1 | 2009 | 16 | 0.330 |
Why?
| HLA-B Antigens | 1 | 2009 | 56 | 0.330 |
Why?
| Dysentery, Bacillary | 1 | 2009 | 9 | 0.330 |
Why?
| Pyroglyphidae | 1 | 2009 | 17 | 0.330 |
Why?
| Interleukin-2 | 1 | 2010 | 419 | 0.330 |
Why?
| Female | 22 | 2021 | 59581 | 0.330 |
Why?
| Lung | 7 | 2022 | 3593 | 0.320 |
Why?
| Autoimmune Diseases | 1 | 2012 | 392 | 0.320 |
Why?
| Maternal Exposure | 3 | 2020 | 138 | 0.320 |
Why?
| Bronchoalveolar Lavage Fluid | 5 | 2019 | 590 | 0.320 |
Why?
| Bacterial Infections | 1 | 2010 | 219 | 0.310 |
Why?
| Esophagitis | 1 | 2009 | 65 | 0.310 |
Why?
| Conjunctivitis, Allergic | 1 | 2008 | 3 | 0.310 |
Why?
| Tears | 1 | 2008 | 14 | 0.300 |
Why?
| eIF-2 Kinase | 1 | 2008 | 24 | 0.300 |
Why?
| Autoantibodies | 2 | 2013 | 1354 | 0.300 |
Why?
| Middle Aged | 12 | 2021 | 26806 | 0.290 |
Why?
| Proto-Oncogene Proteins c-fyn | 1 | 2007 | 12 | 0.290 |
Why?
| GATA3 Transcription Factor | 2 | 2020 | 24 | 0.290 |
Why?
| Gene Expression Regulation | 5 | 2020 | 2324 | 0.280 |
Why?
| Eye Proteins | 1 | 2007 | 71 | 0.280 |
Why?
| Eye | 1 | 2008 | 101 | 0.280 |
Why?
| Lung Diseases, Interstitial | 1 | 2012 | 515 | 0.280 |
Why?
| Fibroblasts | 2 | 2012 | 839 | 0.280 |
Why?
| Protein Kinases | 1 | 2009 | 307 | 0.280 |
Why?
| Killer Cells, Natural | 3 | 2020 | 384 | 0.280 |
Why?
| Dermatitis, Atopic | 1 | 2010 | 307 | 0.280 |
Why?
| Hematopoietic Stem Cells | 1 | 2010 | 345 | 0.280 |
Why?
| Eosinophilia | 1 | 2009 | 186 | 0.280 |
Why?
| Chemotaxis, Leukocyte | 2 | 2007 | 129 | 0.280 |
Why?
| Bronchi | 1 | 2008 | 243 | 0.270 |
Why?
| Adaptation, Psychological | 1 | 2011 | 547 | 0.270 |
Why?
| Respiratory Mucosa | 2 | 2008 | 251 | 0.270 |
Why?
| Bronchoscopy | 3 | 2022 | 246 | 0.270 |
Why?
| Autoimmunity | 1 | 2012 | 818 | 0.270 |
Why?
| Dynamin II | 1 | 2006 | 6 | 0.270 |
Why?
| Air Pollution | 1 | 2008 | 170 | 0.260 |
Why?
| Down-Regulation | 3 | 2021 | 596 | 0.260 |
Why?
| Phosphoproteins | 1 | 2008 | 299 | 0.260 |
Why?
| Chronic Disease | 5 | 2015 | 1593 | 0.260 |
Why?
| Endosomes | 3 | 2013 | 124 | 0.250 |
Why?
| Male | 17 | 2021 | 55663 | 0.250 |
Why?
| Cell Line | 5 | 2020 | 2640 | 0.250 |
Why?
| Antigens | 1 | 2007 | 318 | 0.250 |
Why?
| Adult | 12 | 2021 | 30608 | 0.240 |
Why?
| Respiratory Hypersensitivity | 3 | 2017 | 60 | 0.240 |
Why?
| Environmental Exposure | 1 | 2008 | 377 | 0.240 |
Why?
| Flow Cytometry | 3 | 2014 | 1087 | 0.240 |
Why?
| Protein Binding | 4 | 2012 | 1897 | 0.230 |
Why?
| Mucus | 2 | 2017 | 54 | 0.230 |
Why?
| Intestinal Mucosa | 1 | 2009 | 530 | 0.230 |
Why?
| Nerve Tissue Proteins | 2 | 2009 | 529 | 0.230 |
Why?
| Case-Control Studies | 3 | 2017 | 3008 | 0.230 |
Why?
| NF-kappa B p50 Subunit | 1 | 2023 | 25 | 0.220 |
Why?
| NF-kappa B | 1 | 2007 | 637 | 0.220 |
Why?
| Core Binding Factor Alpha 2 Subunit | 1 | 2023 | 31 | 0.220 |
Why?
| Recurrence | 2 | 2017 | 937 | 0.220 |
Why?
| Stress, Psychological | 1 | 2011 | 945 | 0.210 |
Why?
| Myosin-Light-Chain Kinase | 1 | 2003 | 19 | 0.210 |
Why?
| Helminth Proteins | 1 | 2002 | 19 | 0.210 |
Why?
| Exercise | 1 | 2013 | 1643 | 0.210 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 2 | 2013 | 82 | 0.210 |
Why?
| RNA, Small Interfering | 3 | 2010 | 543 | 0.200 |
Why?
| Obesity | 1 | 2014 | 2514 | 0.200 |
Why?
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2022 | 33 | 0.200 |
Why?
| Prenatal Exposure Delayed Effects | 2 | 2020 | 452 | 0.200 |
Why?
| Th1 Cells | 2 | 2014 | 123 | 0.190 |
Why?
| Growth Inhibitors | 2 | 2012 | 44 | 0.190 |
Why?
| Alternaria | 1 | 2021 | 8 | 0.190 |
Why?
| Immune System | 1 | 2003 | 173 | 0.190 |
Why?
| CD4 Lymphocyte Count | 2 | 2012 | 257 | 0.190 |
Why?
| Cell Survival | 3 | 2010 | 1022 | 0.180 |
Why?
| Caenorhabditis elegans Proteins | 1 | 2002 | 180 | 0.180 |
Why?
| Epitopes, T-Lymphocyte | 2 | 2012 | 170 | 0.180 |
Why?
| Granzymes | 1 | 2020 | 40 | 0.180 |
Why?
| Intimate Partner Violence | 1 | 2021 | 59 | 0.170 |
Why?
| Carrier Proteins | 1 | 2004 | 696 | 0.170 |
Why?
| Paranasal Sinuses | 1 | 2020 | 66 | 0.170 |
Why?
| Mycoplasma pneumoniae | 1 | 2019 | 28 | 0.170 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2020 | 139 | 0.170 |
Why?
| Pneumonia, Mycoplasma | 1 | 2019 | 30 | 0.160 |
Why?
| Leukocytes, Mononuclear | 1 | 2022 | 496 | 0.160 |
Why?
| Aged | 8 | 2017 | 19122 | 0.160 |
Why?
| Particulate Matter | 1 | 2020 | 185 | 0.160 |
Why?
| Enterovirus | 1 | 2019 | 72 | 0.160 |
Why?
| Chemokines | 3 | 2009 | 213 | 0.160 |
Why?
| HIV Infections | 1 | 2012 | 2470 | 0.150 |
Why?
| NIH 3T3 Cells | 2 | 2009 | 137 | 0.150 |
Why?
| Severity of Illness Index | 2 | 2017 | 2542 | 0.150 |
Why?
| Air Pollutants | 2 | 2013 | 244 | 0.150 |
Why?
| Pulmonary Eosinophilia | 1 | 2018 | 26 | 0.150 |
Why?
| Dendritic Cells | 2 | 2012 | 436 | 0.150 |
Why?
| Diagnosis, Differential | 2 | 2012 | 1355 | 0.140 |
Why?
| Ovalbumin | 3 | 2017 | 162 | 0.140 |
Why?
| Young Adult | 4 | 2015 | 10478 | 0.140 |
Why?
| Disease Progression | 2 | 2015 | 2392 | 0.140 |
Why?
| Jurkat Cells | 2 | 2009 | 128 | 0.140 |
Why?
| Serum Amyloid A Protein | 1 | 2016 | 29 | 0.140 |
Why?
| Enterovirus Infections | 1 | 2019 | 160 | 0.140 |
Why?
| Antigens, Plant | 2 | 2014 | 47 | 0.140 |
Why?
| Complement C3a | 1 | 2016 | 33 | 0.140 |
Why?
| Pollen | 2 | 2007 | 24 | 0.130 |
Why?
| Steroids | 1 | 2017 | 146 | 0.130 |
Why?
| Cell Count | 1 | 2017 | 305 | 0.130 |
Why?
| Immunophenotyping | 1 | 2017 | 277 | 0.130 |
Why?
| Actins | 2 | 2009 | 382 | 0.130 |
Why?
| Gene Expression | 2 | 2011 | 1422 | 0.130 |
Why?
| Leukocyte Count | 1 | 2016 | 292 | 0.130 |
Why?
| Chemokine CCL11 | 2 | 2008 | 22 | 0.130 |
Why?
| Superoxide Dismutase | 1 | 2017 | 305 | 0.130 |
Why?
| IgA Deficiency | 1 | 2015 | 5 | 0.130 |
Why?
| Immunoglobulin E | 3 | 2014 | 317 | 0.120 |
Why?
| Interleukin-1beta | 1 | 2017 | 370 | 0.120 |
Why?
| Cholangitis | 1 | 2015 | 19 | 0.120 |
Why?
| Hypertrophy | 1 | 2015 | 111 | 0.120 |
Why?
| Hepatitis | 1 | 2015 | 45 | 0.120 |
Why?
| Rituximab | 2 | 2013 | 151 | 0.120 |
Why?
| Up-Regulation | 3 | 2007 | 812 | 0.120 |
Why?
| Granuloma | 1 | 2015 | 84 | 0.120 |
Why?
| Delayed Diagnosis | 1 | 2015 | 71 | 0.120 |
Why?
| Feedback, Physiological | 1 | 2015 | 68 | 0.120 |
Why?
| Airway Remodeling | 1 | 2015 | 57 | 0.120 |
Why?
| Lymphocyte Depletion | 1 | 2015 | 116 | 0.120 |
Why?
| Sequence Alignment | 1 | 2015 | 325 | 0.120 |
Why?
| Amino Acid Sequence | 3 | 2010 | 1988 | 0.120 |
Why?
| Exons | 1 | 2015 | 303 | 0.120 |
Why?
| Thymus Gland | 1 | 2015 | 296 | 0.110 |
Why?
| Receptors, IgE | 1 | 2014 | 40 | 0.110 |
Why?
| Plant Proteins | 1 | 2014 | 81 | 0.110 |
Why?
| Lung Diseases | 1 | 2020 | 703 | 0.110 |
Why?
| Bone Marrow Transplantation | 1 | 2015 | 241 | 0.110 |
Why?
| Receptors, Leukotriene | 1 | 2013 | 13 | 0.110 |
Why?
| Immunotherapy | 1 | 2017 | 475 | 0.110 |
Why?
| Lipopolysaccharides | 1 | 2016 | 817 | 0.110 |
Why?
| B-Lymphocytes | 2 | 2012 | 772 | 0.110 |
Why?
| Transfection | 2 | 2007 | 870 | 0.110 |
Why?
| Arachidonic Acid | 1 | 2013 | 117 | 0.110 |
Why?
| Interferon-gamma | 2 | 2013 | 723 | 0.110 |
Why?
| Retinal Dystrophies | 1 | 2012 | 3 | 0.110 |
Why?
| Risk Factors | 3 | 2021 | 8637 | 0.110 |
Why?
| CD4-CD8 Ratio | 1 | 2012 | 19 | 0.100 |
Why?
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 12 | 0.100 |
Why?
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 19 | 0.100 |
Why?
| Raltegravir Potassium | 1 | 2012 | 16 | 0.100 |
Why?
| Adaptive Immunity | 1 | 2014 | 157 | 0.100 |
Why?
| Chemokine CCL5 | 1 | 2012 | 45 | 0.100 |
Why?
| Methacholine Chloride | 1 | 2012 | 47 | 0.100 |
Why?
| Base Sequence | 2 | 2009 | 2118 | 0.100 |
Why?
| Models, Biological | 2 | 2012 | 1630 | 0.100 |
Why?
| Dexamethasone | 1 | 2014 | 317 | 0.100 |
Why?
| Oscillometry | 1 | 2012 | 33 | 0.100 |
Why?
| Cloning, Molecular | 2 | 2004 | 524 | 0.100 |
Why?
| Stochastic Processes | 1 | 2012 | 64 | 0.100 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2012 | 164 | 0.100 |
Why?
| Dichloroacetic Acid | 1 | 2011 | 1 | 0.100 |
Why?
| Gene Silencing | 1 | 2012 | 172 | 0.100 |
Why?
| Diagnosis, Computer-Assisted | 1 | 2012 | 64 | 0.100 |
Why?
| Immunologic Factors | 1 | 2013 | 221 | 0.100 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 797 | 0.100 |
Why?
| Rats | 2 | 2010 | 4963 | 0.100 |
Why?
| Signal Processing, Computer-Assisted | 1 | 2012 | 133 | 0.100 |
Why?
| Pressure | 1 | 2012 | 218 | 0.090 |
Why?
| Age of Onset | 1 | 2012 | 448 | 0.090 |
Why?
| Respiratory Sounds | 1 | 2011 | 111 | 0.090 |
Why?
| Headache | 1 | 2011 | 132 | 0.090 |
Why?
| Caloric Restriction | 1 | 2011 | 90 | 0.090 |
Why?
| Forkhead Transcription Factors | 1 | 2011 | 171 | 0.090 |
Why?
| Viral Load | 1 | 2012 | 405 | 0.090 |
Why?
| Th1-Th2 Balance | 1 | 2010 | 10 | 0.090 |
Why?
| Antiretroviral Therapy, Highly Active | 1 | 2012 | 256 | 0.090 |
Why?
| Macrophages | 2 | 2020 | 1266 | 0.090 |
Why?
| Clonal Anergy | 1 | 2010 | 54 | 0.090 |
Why?
| Human Genome Project | 1 | 2010 | 14 | 0.090 |
Why?
| Myocytes, Smooth Muscle | 1 | 2012 | 236 | 0.090 |
Why?
| Algorithms | 2 | 2020 | 1474 | 0.090 |
Why?
| Disease Management | 1 | 2014 | 563 | 0.090 |
Why?
| Glucocorticoids | 1 | 2014 | 534 | 0.090 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2010 | 119 | 0.090 |
Why?
| Antibody Specificity | 2 | 2008 | 176 | 0.090 |
Why?
| Mice, Transgenic | 2 | 2017 | 1953 | 0.090 |
Why?
| Workplace | 1 | 2011 | 220 | 0.090 |
Why?
| Pneumonia | 1 | 2015 | 568 | 0.090 |
Why?
| Age Factors | 1 | 2017 | 2891 | 0.090 |
Why?
| Linear Models | 1 | 2012 | 770 | 0.090 |
Why?
| Microarray Analysis | 1 | 2010 | 119 | 0.080 |
Why?
| Fluorescent Antibody Technique | 1 | 2010 | 396 | 0.080 |
Why?
| Cell Separation | 1 | 2010 | 292 | 0.080 |
Why?
| GTP Phosphohydrolases | 1 | 2009 | 66 | 0.080 |
Why?
| Autoantigens | 1 | 2012 | 397 | 0.080 |
Why?
| Stevens-Johnson Syndrome | 1 | 2009 | 34 | 0.080 |
Why?
| Feeding and Eating Disorders of Childhood | 1 | 2009 | 6 | 0.080 |
Why?
| Social Environment | 1 | 2011 | 283 | 0.080 |
Why?
| Peptides | 1 | 2014 | 848 | 0.080 |
Why?
| Blotting, Western | 1 | 2011 | 1151 | 0.080 |
Why?
| Myosins | 1 | 2009 | 128 | 0.080 |
Why?
| Mycobacterium Infections, Nontuberculous | 1 | 2013 | 336 | 0.080 |
Why?
| Oligopeptides | 1 | 2010 | 235 | 0.080 |
Why?
| Genetic Therapy | 1 | 2010 | 258 | 0.080 |
Why?
| Models, Theoretical | 1 | 2012 | 516 | 0.080 |
Why?
| Psychology | 1 | 2009 | 81 | 0.080 |
Why?
| Kidney | 1 | 2015 | 1184 | 0.080 |
Why?
| Arthritis, Experimental | 1 | 2010 | 132 | 0.080 |
Why?
| Promoter Regions, Genetic | 1 | 2012 | 1133 | 0.080 |
Why?
| Antigen Presentation | 1 | 2009 | 189 | 0.080 |
Why?
| Pharmacogenetics | 1 | 2009 | 149 | 0.080 |
Why?
| Immunity | 1 | 2009 | 121 | 0.080 |
Why?
| Enzyme Induction | 1 | 2008 | 84 | 0.080 |
Why?
| Multiprotein Complexes | 1 | 2009 | 140 | 0.080 |
Why?
| Cytoskeleton | 1 | 2009 | 177 | 0.080 |
Why?
| Autocrine Communication | 1 | 2008 | 42 | 0.080 |
Why?
| Analgesics, Non-Narcotic | 1 | 2009 | 117 | 0.070 |
Why?
| Pilot Projects | 1 | 2012 | 1372 | 0.070 |
Why?
| Protein Transport | 1 | 2009 | 396 | 0.070 |
Why?
| Atherosclerosis | 1 | 2011 | 342 | 0.070 |
Why?
| Clinical Trials as Topic | 1 | 2012 | 934 | 0.070 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 144 | 0.070 |
Why?
| HSP27 Heat-Shock Proteins | 1 | 2007 | 11 | 0.070 |
Why?
| Memory | 1 | 2009 | 209 | 0.070 |
Why?
| Diet | 1 | 2014 | 1077 | 0.070 |
Why?
| Gene Expression Profiling | 2 | 2013 | 1523 | 0.070 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2012 | 692 | 0.070 |
Why?
| Umbilical Veins | 1 | 2007 | 58 | 0.070 |
Why?
| Microscopy, Fluorescence | 1 | 2009 | 398 | 0.070 |
Why?
| Nitrate Reductase (NAD(P)H) | 1 | 2007 | 1 | 0.070 |
Why?
| Microbiota | 1 | 2014 | 649 | 0.070 |
Why?
| Cell Communication | 1 | 2009 | 280 | 0.070 |
Why?
| Biological Evolution | 1 | 2011 | 416 | 0.070 |
Why?
| Bone Marrow Cells | 1 | 2008 | 267 | 0.070 |
Why?
| Bronchitis | 1 | 2007 | 35 | 0.070 |
Why?
| HIV-1 | 1 | 2012 | 768 | 0.070 |
Why?
| Feedback | 1 | 2007 | 145 | 0.070 |
Why?
| Heat-Shock Proteins | 1 | 2007 | 113 | 0.070 |
Why?
| Immunization | 1 | 2009 | 402 | 0.070 |
Why?
| Reactive Oxygen Species | 2 | 2007 | 536 | 0.070 |
Why?
| Polymorphism, Genetic | 1 | 2009 | 612 | 0.070 |
Why?
| Pyrophosphatases | 1 | 2006 | 22 | 0.070 |
Why?
| Transcription, Genetic | 2 | 2013 | 1317 | 0.070 |
Why?
| Phosphoric Diester Hydrolases | 1 | 2006 | 44 | 0.070 |
Why?
| Basophils | 1 | 2006 | 64 | 0.070 |
Why?
| Serum | 1 | 2006 | 57 | 0.060 |
Why?
| Homeodomain Proteins | 1 | 2009 | 464 | 0.060 |
Why?
| Tyrosine | 1 | 2006 | 216 | 0.060 |
Why?
| NADPH Oxidases | 1 | 2005 | 120 | 0.060 |
Why?
| Reproducibility of Results | 1 | 2012 | 2770 | 0.060 |
Why?
| Polymerase Chain Reaction | 1 | 2007 | 995 | 0.060 |
Why?
| Pulmonary Fibrosis | 1 | 2007 | 323 | 0.060 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 928 | 0.060 |
Why?
| src Homology Domains | 1 | 2004 | 33 | 0.060 |
Why?
| Disease Susceptibility | 2 | 2017 | 316 | 0.060 |
Why?
| Antioxidants | 1 | 2007 | 530 | 0.050 |
Why?
| Receptors, Interleukin-5 | 1 | 2002 | 5 | 0.050 |
Why?
| Molecular Sequence Data | 2 | 2010 | 2791 | 0.050 |
Why?
| Chemokines, CC | 1 | 2003 | 28 | 0.050 |
Why?
| Receptors, Interleukin | 1 | 2002 | 39 | 0.050 |
Why?
| Antigen-Presenting Cells | 1 | 2003 | 153 | 0.050 |
Why?
| Protein Kinase Inhibitors | 1 | 2008 | 796 | 0.050 |
Why?
| Monocyte Chemoattractant Proteins | 1 | 2002 | 8 | 0.050 |
Why?
| Chemokines, CXC | 1 | 2002 | 58 | 0.050 |
Why?
| Mucociliary Clearance | 1 | 2022 | 42 | 0.050 |
Why?
| DNA Primers | 1 | 2002 | 514 | 0.050 |
Why?
| Pregnancy | 3 | 2020 | 5527 | 0.050 |
Why?
| Adolescent | 2 | 2010 | 17829 | 0.050 |
Why?
| Genetic Predisposition to Disease | 1 | 2009 | 2102 | 0.050 |
Why?
| Practice Guidelines as Topic | 1 | 2008 | 1400 | 0.050 |
Why?
| Protein Processing, Post-Translational | 1 | 2003 | 399 | 0.050 |
Why?
| Endothelium, Vascular | 1 | 2007 | 848 | 0.050 |
Why?
| Recombinant Proteins | 1 | 2004 | 1233 | 0.050 |
Why?
| Cell Line, Tumor | 1 | 2007 | 2725 | 0.040 |
Why?
| Adjuvants, Immunologic | 1 | 2002 | 206 | 0.040 |
Why?
| Afghanistan | 1 | 2020 | 108 | 0.040 |
Why?
| Oxidative Stress | 2 | 2005 | 1084 | 0.040 |
Why?
| Mutation | 1 | 2010 | 3354 | 0.040 |
Why?
| Particle Size | 1 | 2020 | 317 | 0.040 |
Why?
| Macrophages, Alveolar | 2 | 2018 | 351 | 0.040 |
Why?
| Odds Ratio | 1 | 2021 | 954 | 0.040 |
Why?
| Interleukin-8 | 1 | 2019 | 238 | 0.040 |
Why?
| Chemokine CCL24 | 1 | 2018 | 9 | 0.040 |
Why?
| Interleukin-1 Receptor-Associated Kinases | 1 | 2018 | 20 | 0.040 |
Why?
| Porphyrins | 1 | 2017 | 16 | 0.040 |
Why?
| Pulmonary Alveoli | 1 | 2020 | 374 | 0.040 |
Why?
| RNA | 1 | 2003 | 810 | 0.040 |
Why?
| Receptors, Interleukin-1 | 1 | 2018 | 227 | 0.030 |
Why?
| Treatment Outcome | 1 | 2010 | 9105 | 0.030 |
Why?
| Child, Preschool | 1 | 2009 | 9086 | 0.030 |
Why?
| Prevalence | 1 | 2021 | 2252 | 0.030 |
Why?
| Receptors, Aryl Hydrocarbon | 1 | 2013 | 39 | 0.030 |
Why?
| Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 17 | 0.030 |
Why?
| STAT1 Transcription Factor | 1 | 2013 | 65 | 0.030 |
Why?
| Hypersensitivity, Immediate | 1 | 2013 | 46 | 0.030 |
Why?
| Administration, Inhalation | 2 | 2007 | 642 | 0.030 |
Why?
| Genotype | 1 | 2017 | 1775 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 316 | 0.030 |
Why?
| Cross-Sectional Studies | 1 | 2021 | 4407 | 0.020 |
Why?
| Histocompatibility Antigens Class II | 1 | 2012 | 353 | 0.020 |
Why?
| Tomography, X-Ray Computed | 1 | 2020 | 2326 | 0.020 |
Why?
| Quality of Life | 1 | 2021 | 2359 | 0.020 |
Why?
| Epitope Mapping | 1 | 2010 | 51 | 0.020 |
Why?
| RNA, Messenger | 1 | 2017 | 2559 | 0.020 |
Why?
| Child | 1 | 2009 | 18366 | 0.020 |
Why?
| Computational Biology | 1 | 2012 | 531 | 0.020 |
Why?
| Epitopes | 1 | 2010 | 436 | 0.020 |
Why?
| Cohort Studies | 1 | 2017 | 4903 | 0.020 |
Why?
| Tocopherols | 1 | 2007 | 22 | 0.020 |
Why?
| Chloride Channels | 1 | 2007 | 35 | 0.020 |
Why?
| Mucins | 1 | 2007 | 61 | 0.020 |
Why?
| IgG Deficiency | 1 | 2006 | 8 | 0.020 |
Why?
| Histamine Release | 1 | 2006 | 22 | 0.020 |
Why?
| Ascorbic Acid | 1 | 2007 | 110 | 0.020 |
Why?
| Acetylcysteine | 1 | 2007 | 142 | 0.020 |
Why?
| Glutathione Disulfide | 1 | 2005 | 26 | 0.020 |
Why?
| Neutrophil Infiltration | 1 | 2005 | 94 | 0.020 |
Why?
| Plant Extracts | 1 | 2007 | 155 | 0.020 |
Why?
| Mice, SCID | 1 | 2005 | 320 | 0.010 |
Why?
| Aldehydes | 1 | 2005 | 142 | 0.010 |
Why?
| Epithelium | 1 | 2005 | 298 | 0.010 |
Why?
| Mice, Inbred NOD | 1 | 2005 | 561 | 0.010 |
Why?
| Chemokine CCL7 | 1 | 2002 | 3 | 0.010 |
Why?
| Oxidation-Reduction | 1 | 2005 | 927 | 0.010 |
Why?
| Receptors, CCR3 | 1 | 2002 | 8 | 0.010 |
Why?
| Dose-Response Relationship, Immunologic | 1 | 2002 | 76 | 0.010 |
Why?
| Receptors, Chemokine | 1 | 2002 | 43 | 0.010 |
Why?
| Chemokine CXCL10 | 1 | 2002 | 34 | 0.010 |
Why?
| Ozone | 1 | 2002 | 99 | 0.010 |
Why?
|
|
Alam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|